Mill Creek Capital Advisors LLC Sells 2,732 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mill Creek Capital Advisors LLC lowered its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 28.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 6,985 shares of the exchange traded fund’s stock after selling 2,732 shares during the period. Mill Creek Capital Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $690,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Affinity Asset Advisors LLC boosted its stake in shares of SPDR S&P Biotech ETF by 105.4% in the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock valued at $3,481,000 after purchasing an additional 737,550 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of SPDR S&P Biotech ETF by 30.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after buying an additional 730,000 shares during the period. Mirae Asset Securities USA Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $55,626,000. Assetmark Inc. increased its stake in SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after purchasing an additional 588,489 shares in the last quarter. Finally, Jane Street Group LLC raised its stake in shares of SPDR S&P Biotech ETF by 68.7% in the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 5.3 %

Shares of XBI opened at $91.83 on Friday. The company has a market capitalization of $7.00 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $69.32 and a 12 month high of $105.47. The stock has a 50 day moving average of $98.95 and a 200 day moving average of $96.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.